The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies

被引:11
作者
Guo, Haochuan [1 ]
Xu, Xinru [1 ]
Zhang, Jiaxi [1 ]
Du, Yajing [1 ]
Yang, Xinbing [1 ]
He, Zhiheng [2 ,3 ]
Zhao, Linjie [2 ,3 ]
Liang, Tingming [1 ]
Guo, Li [2 ,3 ]
机构
[1] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Peoples R China
[2] Nanjing Univ Posts & Telecommun, State Key Lab Organ Elect & Informat Displays, 9 Wenyuan Rd, Nanjing 210023, Peoples R China
[3] Nanjing Univ Posts & Telecommun, Inst Adv Mat IAM, 9 Wenyuan Rd, Nanjing 210023, Peoples R China
基金
中国国家自然科学基金;
关键词
preclinical animal models; anti-cancer therapy; drug development; personalized therapy; REPEAT-DOSE TOXICITY; MOUSE MODELS; GENOMIC INSTABILITY; CYNOMOLGUS MONKEY; CARCINOGENICITY; HALLMARKS; SAFETY; REQUIREMENTS; GENERATION; CHALLENGES;
D O I
10.3390/ph17081048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The establishment and utilization of preclinical animal models constitute a pivotal aspect across all facets of cancer research, indispensably contributing to the comprehension of disease initiation and progression mechanisms, as well as facilitating the development of innovative anti-cancer therapeutic approaches. These models have emerged as crucial bridges between basic and clinical research, offering multifaceted support to clinical investigations. This study initially focuses on the importance and benefits of establishing preclinical animal models, discussing the different types of preclinical animal models and recent advancements in cancer research. It then delves into cancer treatment, studying the characteristics of different stages of tumor development and the development of anti-cancer drugs. By integrating tumor hallmarks and preclinical research, we elaborate on the path of anti-cancer drug development and provide guidance on personalized cancer therapy strategies, including synthetic lethality approaches and novel drugs widely adopted in the field. Ultimately, we summarize a strategic framework for selecting preclinical safety experiments, tailored to experimental modalities and preclinical animal species, and present an outlook on the prospects and challenges associated with preclinical animal models. These models undoubtedly offer new avenues for cancer research, encompassing drug development and personalized anti-cancer protocols. Nevertheless, the road ahead continues to be lengthy and fraught with obstacles. Hence, we encourage researchers to persist in harnessing advanced technologies to refine preclinical animal models, thereby empowering these emerging paradigms to positively impact cancer patient outcomes.
引用
收藏
页数:30
相关论文
共 50 条
[31]   Current status and evolution of preclinical drug development models of epithelial ovarian cancer [J].
Konstantinopoulos, Panagiotis A. ;
Matulonis, Ursula A. .
FRONTIERS IN ONCOLOGY, 2013, 3
[32]   Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity [J].
Rocca, Carmine ;
De Francesco, Ernestina Marianna ;
Pasqua, Teresa ;
Granieri, Maria Concetta ;
De Bartolo, Anna ;
Cantafio, Maria Eugenia Gallo ;
Muoio, Maria Grazia ;
Gentile, Massimo ;
Neri, Antonino ;
Angelone, Tommaso ;
Viglietto, Giuseppe ;
Amodio, Nicola .
BIOMEDICINES, 2022, 10 (03)
[33]   Methadone as an effective anti-cancer drug. Ethical issues [J].
Steger, Florian ;
Gierschik, Peter ;
Rubeis, Giovanni .
ONKOLOGE, 2018, 24 (11) :915-920
[34]   Electrophysiological Effects of the Anti-Cancer Drug Lapatinib on Cardiac Repolarization [J].
Lee, Hyang-Ae ;
Kim, Eun-Joo ;
Hyun, Sung-Ae ;
Park, Sung-Gurl ;
Kim, Ki-Suk .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107 (01) :614-618
[35]   An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs [J].
Bhattarai, Deepak ;
Singh, Sarbijt ;
Jang, Yerin ;
Han, Seung Hyeon ;
Lee, Kyeong ;
Choi, Yongseok .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (19) :2156-2168
[36]   Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy A Review of Current Literature [J].
Qureshi, Zaheer ;
Zaheer, Zaofashan ;
Asghar, Zoha ;
Bakhtiar, Muhammad ;
Fatima, Eeshal ;
Altaf, Faryal .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (05) :235-241
[37]   Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade [J].
Nirmala Tilija Pun ;
Won-Jun Jang ;
Chul-Ho Jeong .
Archives of Pharmacal Research, 2020, 43 :475-488
[38]   Xenograft models for preclinical drug testing: Implications for adrenocortical cancer [J].
Luconi, Michaela ;
Mannelli, Massimo .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 351 (01) :71-77
[39]   Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade [J].
Tilija Pun, Nirmala ;
Jang, Won-Jun ;
Jeong, Chul-Ho .
ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (05) :475-488
[40]   Reassessing the Potential of Myb-targeted Anti-cancer Therapy [J].
Liu, Xiaofeng ;
Xu, Yunxiao ;
Han, Liping ;
Yi, Yan .
JOURNAL OF CANCER, 2018, 9 (07) :1259-1266